$5.22
00.00%
After Hours: Sep 20, 4:48 PM EDT
15 minutes delayed
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of INmune Bio using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.50 | $-0.63 | 20.6 % |
Mar 2024 | 2024-05-09 | $-0.61 | $-0.53 | -15.1 % |
Dec 2023 | 2024-03-28 | $-0.47 | $-0.44 | -6.82 % |
Sep 2023 | 2023-11-01 | $-0.48 | $-0.41 | -17.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $14.00K | $30.00K | -53.3 % |
Dec 2023 | 2024-03-28 | $28.00K | $40.00K | -30.0 % |
Sep 2021 | 2021-11-03 | $14.00K | $970.00K | -98.6 % |
INmune Bio (INMB) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.50, which beat the estimate of $-0.63.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.